- Home
- Investors
- Annual general meeting
- Results of voting at AGMs
Results of voting at AGMs
Issued - Wednesday 17th May 2006, London - LSE AnnouncementVoting on the resolutions put to each AGM is on a poll rather than by a show of hands. The results of the poll are announced to the London Stock Exchange, via the Regulatory Information Service, as soon as practicable after the AGM. They are also published on this page.
Results of AGM
GlaxoSmithKline (GSK) announces that at today's Annual General
Meeting all resolutions, including
those electing
and re-electing Board members, were passed by shareholders.
The following table shows the votes cast for each resolution:
| Resolution | Total Votes For* | % | Total Votes Against | % | Total Votes Cast | Abstentions ** | |
|---|---|---|---|---|---|---|---|
| 1. | Adoption of Financial Statements | 3,855,039,326 |
94.59% |
220,367,300 |
5.41% |
4,075,406,626 |
101,966,993 |
| 2. | Approval of the Remuneration Report | 3,813,702,842 |
92.25% |
320,348,275 |
7.75% |
4,134,051,117 |
43,322,502 |
| 3. | Election of Dr Moncef Slaoui | 4,104,069,659 |
99.29% |
29,389,909 |
0.71% |
4,133,459,568 |
43,914,051 |
| 4. | Election of Tom de Swaan | 4,152,473,410 |
99.67% |
13,811,481 |
0.33% |
4,166,284,891 |
11,088,728 |
| 5. | Re-election of Larry Culp | 4,139,769,880 |
99.36% |
26,761,365 |
0.64% |
4,166,531,245 |
10,842,374 |
| 6. | Re-election of Sir Crispin Davis | 4,139,913,421 |
99.36% |
26,702,005 |
0.64% |
4,166,615,426 |
10,758,193 |
| 7. | Re-election of Dr Ronaldo Schmitz | 4,130,055,407 |
99.12% |
36,639,628 |
0.88% |
4,166,695,035 |
10,678,584 |
| 8. | Re-appointment of Auditors | 4,105,860,589 |
99.36% |
26,520,893 |
0.64% |
4,132,381,482 |
44,992,137 |
| 9. | Remuneration of Auditors | 4,145,609,945 |
99.48% |
21,844,882 |
0.52% |
4,167,454,827 |
9,918,792 |
| 10. | To authorise the company to make donations to EU Political Organisations & incur EU Political Expenditure |
4,081,281,019 |
98.11% |
78,621,700 |
1.89% |
4,159,902,719 |
17,470,900 |
| 11. | Authority to allot shares | 4,080,970,037 |
97.99% |
83,853,325 |
2.01% |
4,164,823,362 |
12,550,257 |
| 12. | Disapplication of pre-emption rights*** |
4,132,232,501 |
99.10% |
37,630,848 |
.90% |
4,169,863,349 |
7,510,270 |
| 13. | Authority for the Company to purchase its own shares*** |
4,151,078,987 |
99.61% |
16,151,515 |
0.39% |
4,167,230,502 |
10,143,117 |
Notes:
* Includes discretionary votes.
** An abstention is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" a resolution.
*** Indicates Special Resolutions requiring a 75% majority.
The following table provides further relevant information:
GlaxoSmithKline's Sixth AGM (2006) |
GlaxoSmithKline's Fifth AGM (2005) |
|
|---|---|---|
| Issued share capital (excluding Treasury Shares) |
5,820,406,967 |
5,852,415,354 |
| Total votes cast and abstentions lodged as a % of GSK's issued share capital (excluding Treasury Shares) | 71.77% |
70.56% |
| Total shareholder population | 192,331 |
209,029 |
| Total number of proxies lodged | 15,907 |
16,156 |
| % of shareholders who lodged proxies | 8.27% |
7.73% |
| Number of shareholders, corporate representatives and proxies who attended the AGM | 290 |
286 |
S M Bicknell
Company Secretary
17th May 2006
Back to top